In another murine B cell lymphoma model, the synthetic nucleotide STING agonist cyclic dithio-modified diadenosine (ADU-S100) led to host STING-dependent clearance of the tumor, with intratumoral injection resulting in complete local tumor clearance and scar formation [145]. The gene discussed is STING1; the disease is B-cell non-Hodgkin lymphoma.